TrialHepatology (Baltimore, Md.)2016

Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence.

Fred Poordad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.